Alnylam Pharmaceuticals, Inc. (ALNY)
301.11
+3.18
(+1.07%)
USD |
NASDAQ |
May 05, 16:00
301.11
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap : 40.20B for May 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 881.82B |
| Pfizer Inc. | 150.75B |
| Aldeyra Therapeutics, Inc. | 103.51M |
| Ionis Pharmaceuticals, Inc. | 12.44B |
| Glaukos Corp. | 7.836B |
Market Cap Related Metrics
| PE Ratio | 71.55 |
| PS Ratio | 9.526 |
| Price to Book Value | 37.38 |
| Price to Free Cash Flow | 63.67 |
| Price | 301.11 |
| Earnings Yield | 1.40% |
| Operating PE Ratio | 54.29 |
| Normalized PE Ratio | 73.02 |